📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Bayer hires law firm to probe Monsanto data collection

Published 05/21/2019, 08:05 AM
© Reuters. FILE PHOTO: Headquarters and main plant of German pharmaceutical and chemical maker Bayer AG in Leverkusen
BAYGN
-
MON
-

BERLIN (Reuters) - Bayer (DE:BAYGN) on Tuesday hired law firm Sidley Austin to investigate a Europe-wide data collection scheme run by its Monsanto (NYSE:MON) unit, which targeted journalists, politicians and other stakeholders to influence the debate on pesticides.

Bayer last week admitted that Monsanto, which it acquired for $63 billion last year, had gathered non-public information as part of the campaign, which French media said sought to influence the public debate on pesticides and genetically modified products.

Bayer faces potentially heavy litigation costs from U.S. class-action lawsuits in which plaintiffs claim that its Roundup weedkiller, which contains glyphosate, causes cancer. Bayer disputes this.

In a Q&A document posted on its website on Tuesday, Bayer said U.S public relations and marketing agency FleishmanHillard, on behalf of Monsanto, had mapped stakeholders in France, Germany, Italy, Netherlands, Poland, Spain, and United Kingdom as well as stakeholders related to EU institutions.

Sidley Austin will investigate how many stakeholders were included in those files and whether people from other countries could also be affected, Bayer said.

The law firm would then contact affected people, most of them journalists, politicians and scientists, no later than by the end of the coming week.

French prosecutors said they had opened an inquiry after newspaper Le Monde filed a complaint alleging that Monsanto had kept a file of 200 names in hopes of influencing their positions.

Bayer has ended its PR collaboration with FleishmanHillard, but continues to work with the firm on marketing projects.

© Reuters. FILE PHOTO: Headquarters and main plant of German pharmaceutical and chemical maker Bayer AG in Leverkusen

Bayer shares have shed more than 40 percent since a first adverse U.S. judgment on Roundup last August, leaving the company with a market capitalization smaller than the price it paid for Monsanto.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.